Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGAV | P06756 | 19/20 | 0.67 |
| ▸ | ITGB3 | P05106 | 12/20 | 0.67 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.46 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.46 |
| ▸ | ITGB6 | P18564 | 7/20 | 0.45 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20156298 | 0.92 | ITGAV (0.57) | ITGAVITGB3ITGA2BITGB6 | |
| SCHEMBL20156338 | 0.87 | ITGAV (0.63) | ITGAVITGB3ITGB1ITGA2BITGA4 | |
| SCHEMBL20156054 | 0.82 | ITGAV (0.47) | ITGAVITGB3ITGB1ITGA2BITGA4 | |
| SCHEMBL20156055 | 0.82 | ITGAV (0.47) | ITGAVITGB3ITGB1ITGA2BITGA4 | |
| SCHEMBL20156297 | 0.81 | ITGAV (0.51) | ITGAVITGB3ITGB1ITGA2BITGA4 | |
| SCHEMBL23912887 | 0.81 | ITGAV (0.48) | ITGAVITGB3ITGB1ITGA4ITGB6 | |
| SCHEMBL20158287 | 0.79 | ITGAV (0.72) | ITGAVITGB3ITGB6 | |
| SCHEMBL20142830 | 0.79 | ITGAV (0.72) | ITGAVITGB3ITGB6 | |
| SCHEMBL21317538 | 0.79 | ITGAV (0.72) | ITGAVITGB3ITGB6 | |
| SCHEMBL20142831 | 0.79 | ITGAV (0.72) | ITGAVITGB3ITGB6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3538527-B1 | AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2021-10-13 | — | — | EP | disclosed |
| WO-2018089358-A1 | AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-05-17 | — | — | WO | disclosed |